Edwards Lifescience Reiterates 2023 Guidance Of 10-13% Constant Currency Sales Growth
Portfolio Pulse from Benzinga Newsdesk
Edwards Lifesciences has reiterated its 2023 guidance of 10-13% constant currency sales growth.
October 25, 2023 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences has confirmed its 2023 guidance of 10-13% constant currency sales growth.
The reiteration of the 2023 guidance by Edwards Lifesciences indicates the company's confidence in its future performance. This could potentially have a positive impact on the company's stock price as it shows stability and potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100